Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Suberoylanilide hydroxamic acid (compound)
Most Correlated Studies
- Pancreatic cell lines treated with chromatin-targeting small molecules
- Pre-cursor B cell acute lymphoblastic leukemia cells and patient samples treated with vorinostat
- CD4-positive T cells from healthy donors treated with suberoylanilide hydroxamic acid
- Foreskin fibroblast BJ cells tumorigenic or normal treated with vorinostat
- Prostate cancer cells treated with Genistein and Vorinostat
Most Relevant Literature
- Histone Methyltransferases as a New Target for Epigenetic Action of Vorinostat.
- Exploring the synergistic behavior of paclitaxel and vorinostat upon co-loading in albumin nanoparti…
- The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs.
- Box-Behnken assisted development and validation of high-performance liquid chromatography method for…
- Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal.
Most Relevant Clinical Trials
- Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors
- Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
- Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Loca…
- Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
- Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Sma…
